Taysha Gene Therapies, Inc.
TSHANasdaqCIK 1806310HealthcareFiscal year ends Dec 31
Reports and events: 133 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1116:07 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-344610 |
| 2026-08-1116:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-344594 |
| 2026-06-2516:26 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-282855 |
| 2026-06-2208:14 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-276738 |
| 2026-06-0216:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-253478 |
| 2026-05-0608:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-207666 |
| 2026-05-0608:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-207633 |
| 2026-04-2208:01 ET | DEF 14A | Proxy statementPeriod 2026-06-01 | 0001193125-26-168525 |
| 2026-03-1908:31 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-115202 |
| 2026-03-1908:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-115177 |
| 2025-11-0407:12 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-263543 |
| 2025-11-0406:54 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-263506 |
| 2025-10-1616:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-241415 |
| 2025-10-0908:24 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-235212 |
| 2025-10-0208:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-227505 |
| 2025-08-1210:48 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-107010 |
| 2025-08-1208:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-178504 |
| 2025-06-0321:54 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-015487 |
| 2025-06-0307:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-133745 |
| 2025-05-2916:38 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-130709 |
| 2025-05-2906:02 ET | 8-K/A | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-129849 |
| 2025-05-2816:13 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-129494 |
| 2025-05-1508:40 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-072036 |
| 2025-05-1508:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-120329 |
| 2025-04-2116:01 ET | DEF 14A | Proxy statementPeriod 2025-06-02 | 0001193125-25-087214 |
| 2025-02-2608:44 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-027348 |
| 2025-02-2608:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-035882 |
| 2024-11-1316:38 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-126416 |
| 2024-11-1316:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-257205 |
| 2024-08-1208:32 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-095082 |
| 2024-08-1208:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-198392 |
| 2024-06-2617:14 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-169191 |
| 2024-06-2606:14 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-168479 |
| 2024-06-1807:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-163050 |
| 2024-05-3016:02 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-150323 |
| 2024-05-1416:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-138253 |
| 2024-05-1416:12 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-059555 |
| 2024-04-1816:13 ET | DEF 14A | Proxy statementPeriod 2024-05-29 | 0001193125-24-100792 |
| 2024-03-1916:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-071321 |
| 2024-03-1916:15 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-033484 |
| 2024-01-1008:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-005637 |
| 2023-12-2016:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-299942 |
| 2023-11-1516:29 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-23-277914 |
| 2023-11-1416:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-277165 |
| 2023-11-1416:17 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-063734 |
| 2023-11-0116:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-268173 |
| 2023-10-0507:00 ET | DEF 14A | Proxy statementPeriod 2023-11-15 | 0001193125-23-251065 |
| 2023-09-2608:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-241943 |
| 2023-09-1916:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-237632 |
| 2023-08-2907:00 ET | 8-K | 8.01 Other events | 0001193125-23-222964 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:57 ET. Listed shows no prices and gives no investment advice.